Sterile Ophthalmic CDMO—Pillar5 Pharma, Inc. provides a competitive edge through various partners as an innovative Contract Development Manufacturing Organization with the vision to be the most competitive & valued sterile ophthalmic & solid dose CDMO competing in the Global Market. Health Canada and FDA approved, offering expertise in sterile ophthalmic, including preservative free (OSD), solid dose, dossiers, and analytical services. With recent sterile expansion, Pillar5 sterile capacity will be doubled in size by 2017. Pillar5 continues to receive the highest quality ranking possible of 100% with major customers. Offering excellence in: operations; quality; business; and customer service providing cost effective solutions to their customers.